Financing
Noncontrolling interest transactions and other
Guardant Health Noncontrolling interest transactions and other decreased by 685.1% to -$4.48M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 149100.0%, from -$3K to -$4.48M. Over 2 years (FY 2021 to FY 2025), Noncontrolling interest transactions and other shows an upward trend with a 96.6% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2021
Last reportedQ1 2026May 7, 2026
Metric ID:
lin_noncontrolling_interest_transactions_and_otherHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$232.5K | -$232.5K | -$232.5K | -$18K | -$18K | -$19K | $5.95M | $118K | $257K | -$438K | -$31K | -$3K | -$41K | $2.88M | $765K | -$4.48M |
| QoQ Change | — | +0.0% | +0.0% | +92.3% | +0.0% | -5.6% | >999% | -98.0% | +117.8% | -270.4% | +92.9% | +90.3% | <-999% | >999% | -73.4% | -685.1% |
| YoY Change | — | — | — | +92.3% | — | — | — | +755.6% | >999% | <-999% | -100.5% | -101.2% | +90.6% | >999% | — | <-999% |
Range-$4.48M – $5.95M
CAGR+120.1%
Avg YoY Growth<-999%
Median YoY Growth+90.6%
Current Streak2 quarters decline
Noncontrolling interest transactions and other at Other Companies
Frequently Asked Questions
- What is Guardant Health's noncontrolling interest transactions and other?
- Guardant Health (GH) reported noncontrolling interest transactions and other of -$4.48M in Q1 2026.
- How has Guardant Health's noncontrolling interest transactions and other changed year-over-year?
- Guardant Health's noncontrolling interest transactions and other decreased by 149100.0% year-over-year, from -$3K to -$4.48M.
- What is the long-term trend for Guardant Health's noncontrolling interest transactions and other?
- Over 2 years (2021 to 2025), Guardant Health's noncontrolling interest transactions and other has grown at a 96.6% compound annual growth rate (CAGR), from -$930K to $3.6M.